nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absolute neutrophil count by Duffy status among healthy Black and African American adults
|
Merz, Lauren E. |
|
|
7 |
3 |
p. 317-320 |
artikel |
2 |
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas
|
Rindone, Giovanni |
|
|
7 |
3 |
p. 314-316 |
artikel |
3 |
A novel, effective, and efficient strategy for treating sickle cell vaso-occlusive events in the infusion center setting
|
Peslak, Scott A. |
|
|
7 |
3 |
p. 410-413 |
artikel |
4 |
Antileukemic properties of the kinase inhibitor OTSSP167 in T-cell acute lymphoblastic leukemia
|
Bridges, Cory Seth |
|
|
7 |
3 |
p. 422-435 |
artikel |
5 |
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT
|
Tran, Misha C. |
|
|
7 |
3 |
p. 285-292 |
artikel |
6 |
A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopenia
|
Grainger, John |
|
|
7 |
3 |
p. 396-405 |
artikel |
7 |
CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse
|
Vu, Khoan |
|
|
7 |
3 |
p. 375-378 |
artikel |
8 |
Cheng PTM, Villa D, Tonseth RP, et al. Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach. Blood Adv. 2021;5(18):3647-3655.
|
|
|
|
7 |
3 |
p. 336-339 |
artikel |
9 |
Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM
|
Kriegsmann, Katharina |
|
|
7 |
3 |
p. 379-383 |
artikel |
10 |
Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation
|
Acosta-Medina, Aldo A. |
|
|
7 |
3 |
p. 340-350 |
artikel |
11 |
Differences in wild-type– and R338L-tenase complex formation are at the root of R338L-factor IX assay discrepancies
|
Foley, Jonathan H. |
|
|
7 |
3 |
p. 458-467 |
artikel |
12 |
Editorial Board
|
|
|
|
7 |
3 |
p. i |
artikel |
13 |
Enhanced VWF clearance in low VWF pathogenesis: limitations of the VWFpp/VWF:Ag ratio and clinical significance
|
Doherty, Dearbhla |
|
|
7 |
3 |
p. 302-308 |
artikel |
14 |
Front Matter
|
|
|
|
7 |
3 |
p. ii |
artikel |
15 |
Impact of IDH1 and IDH2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation
|
Bill, Marius |
|
|
7 |
3 |
p. 436-444 |
artikel |
16 |
Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populations
|
Ren, Jingjing |
|
|
7 |
3 |
p. 445-457 |
artikel |
17 |
Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies
|
Miljkovic, Milos D. |
|
|
7 |
3 |
p. 384-394 |
artikel |
18 |
Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance
|
Johnson, Kate M. |
|
|
7 |
3 |
p. 365-374 |
artikel |
19 |
Menghrajani K, Gomez-Arteaga A, Madero-Marroquin R, et al. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Adv. 2022;6(3):828-847.
|
|
|
|
7 |
3 |
p. 395 |
artikel |
20 |
Neighborhood disadvantage, health status, and health care utilization after blood or marrow transplant: BMTSS report
|
Wolfson, Julie A. |
|
|
7 |
3 |
p. 293-301 |
artikel |
21 |
Npm1 haploinsufficiency in collaboration with MEIS1 is sufficient to induce AML in mice
|
Muranyi, Andrew |
|
|
7 |
3 |
p. 351-364 |
artikel |
22 |
Persistence of chronic inflammation after regular blood transfusion therapy in sickle cell anemia
|
Dembélé, Abdoul Karim |
|
|
7 |
3 |
p. 309-313 |
artikel |
23 |
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study
|
Quinn, Charles T. |
|
|
7 |
3 |
p. 414-421 |
artikel |
24 |
Single-cell analysis of Sézary syndrome reveals novel markers and shifting gene profiles associated with treatment
|
Borcherding, Nicholas |
|
|
7 |
3 |
p. 321-335 |
artikel |
25 |
White blood cell ranges and frequency of neutropenia by Duffy genotype status
|
Bagheri, Minoo |
|
|
7 |
3 |
p. 406-409 |
artikel |